Back A A A Font Size Receive E-mail Alerts Press Releases

MicroPort® Orthopedics Holds First University of Hong Kong - Shenzhen Hospital Total Knee Arthroplasty Technique (TKA) Advancement Course


Shenzhen, China –The first Total Knee Arthroplasty Technique Advancement Course, which was co-organized by MicroPort® Orthopedics and University of Hong Kong - Shenzhen Hospital, took place on August 29. A total of 12 orthopedic surgeons from the Chinese provinces of Jiangsu, Sichuan, Shandong, Liaoning and Chongqing took part in the 2-day course on Medial-Pivot Knee TKA technique at University of Hong Kong - Shenzhen Hospital.
The University of Hong Kong Shenzhen hospital is a major comprehensive public hospital built by the Shenzhen municipal government with introduction of modern management model by the University of Hong Kong. Dr. Chun-Hoi Yan, who is clinical professor with Department of Orthopaedics and Traumatology of the University of Hong Kong and Chief of Division of Joint Replacement Surgery at Queen Mary Hospital, is appointed as consultant of the Division of Joint Replacement Surgery at the Shenzhen hospital. Professor Yan and his team own ripe experience in the teaching of total knee arthroplasty technique. The training closely touched on the total knee arthroplasty technique, Medial-Pivot knee's design rationale, and clinical application and advantages, with a focus on transformation from theory to practice. With appropriate course planning and small group learning, the attending surgeons gained a more in-depth and comprehensive knowledge of MicroPort® Orthopedics' Medial-Pivot knee product, instruments and surgical technique within only two days.
Professor Yan started the training with "Kinematics of Normal Knee and Knee Implants". With the comparison and analysis of the kinematics of normal knee and knee implants, he explained to the surgeons in a progressive manner how MicroPort® Orthopedics' Medial-Pivot knee imitates the kinematics of normal knees through its unique highly-bionic and autonomical design rationale, which results in the restoration of normal knee function and a more natural feeling for the patients. Afterwards, Profess Yan held a seminar on total knee arthroplasty to introduce surgical experience and skills, and also prompted the surgeons to look into the total knee arthroplasty.
In the following session of surgery demonstration, Professor Yan demonstrated four surgeries using EVOLUTION® Medial-Pivot Knee System and had detailed and clear explanation about the surgery steps, instrument use and precautions. The 12 surgeons closely observed the clinical application and surgical skills of Medial-Pivot knee. As one of the world's top knee systems, EVOLUTION® owns widespread market influence and is very well-known. Also, the patients who had undergone the surgeries using EVOLUTION® commented that the knee system demonstrated outstanding stability and comfort level. In the end, Qi Zhu and Nan Lou, two doctors from University of Hong Kong - Shenzhen Hospital, spoke about the researches and experience of the hospital staff regarding the complications after knee replacements and the recovery after the surgery.
The two-day course deepened the surgeons' understanding of the rationale and product advantages of Medial-Pivot knee, with the related questions about Medial-Pivot knee and total knee arthroplasty being asked and answered thoroughly immediately. The surgeons gave positive feedbacks and comments, saying that they had further mastered the skills of Medial-Pivot knee replacement during the course, which would lay a good groundwork of theory and practice for the future performance of such surgery.
Thus far, the Total Knee Arthroplasty Technique Advancement Course co-organized by MicroPort® Orthopedics and Queen Mary Hospital has been successfully held for six times, with more and more orthopedic surgeons benefitting from the course. In future, MicroPort® Orthopedics will continually promote the scientific exchanges and help even more orthopedic surgeons understand and employ Medial-Pivot knee products in various forms including the Total Knee Arthroplasty Technique Advancement Course, so as to benefit the patients.

About MicroPort®

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 8 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Cardiac Rhythm Management, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort® is dedicated to bringing about a people-centric SuperCluster of emerging medical technologies to provide the best yet accessible ways & means to prolong and reshape lives.

For more information, please refer to:

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort®'s management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 1998-2019 MicroPort Scientific Corporation

Leanne Li
Board Secretary and Vice President of Corporate General Affairs
MicroPort Scientific Corporation
Tel: (86)(21) 38954600-6957


[Prev]:Experts from Pakistan Society of Interventional Cardiology Visits MicroPort®
[Next]:MicroPort® Takes Firehawk® to Encore Seoul 2018 in Korea